Dent Sci 126: Periodontology Flashcards
In detecting active periodontal disease, detecting the BACTERIA as an indicator for active disease has:
Low sensitivity, high specificity
Highest quality of evidence
Meta-analysis of randomized controlled clinical trials
Systemic antibiotics would be of LEAST additional value in tx of:
Chronic periodontitis that responds to conventional tx; MORE ADDITIONAL VALUE in – chronic periodontitis that DOES NOT respond to conventional tx; aggressive periodontitis that DOES NOT respond to convential tx; patients with uncontrolled diabetes + chronic periodontitis
Gingivitis VS. Periodontitis
In periodontitis, there is loss of connective tissue attachment
Clinical attachment level (CAL) is measured from:
CEJ to the bottom of the probeable sulcus or pocket
Major problem with use of antimicrobials is periodontal pockets have been:
maintaining high concentration of antimicrobial in the pocket
All of the following medicaments have been marketed in the US in controlled release local delivery anti-microbial systems for tx of chronic periodontitis EXCEPT:
Chloropromazine – others marketed: doxycycline, minocycline, tetracycline, chlorohexidine
“Zero order kinetics” of a drug delivery system implies:
the drug is released in constant amounts, even as the amount of drug remaining at the site is decreasing.
Gingival crevicular fluid (GCF) is a clear serous fluid from inflamed gingiva that is:
a transudate of serum and tissue fluids
Dominant features of the progression of periodontitis are inflammation-induced bone and connective tissue lysis, the search for risk predictors of disease has centered on all the following except:
Cell wall components of Porphyromonas gingivalis and other pathogens — NOT EXCEPTIONS: tissue breakdown products, host-derived enzymes + their inhibitors, inflammatory mediators + host-response modifiers
For maximum clinical utility a GCF marker or risk predictor of the progression of periodontitis should be tested in:
who are in a maintenance care program
The primary cellular sources of matrix metalloproteinase-8 (MMP-8) in GCF are:
neutrophils
Low-dose doxycycline (PerioStat) inhibits matrix metalloproteinases because the antibiotic is a:
chelating agent
In a patient with untreated chronic periodontitis, most of the IgG and IgM in whole saliva comes from:
Gingival crevicular fluid (GCF)
In the whole saliva of an untreated patient with chronic periodontitis, this one is not a component of innate immunity:
Secretory IgA2 – all the following are components on innate immunity: B-definsins, neutrophils, interluekin-1 (IL-1), complement
The majority of IgG found in whole saliva comes from:
gingival crevicular fluid (GCF)
Experimental gingivitis studies in humans have histologically shown that extensive loss of gingival connective tissue adjacent to pocket epithelium occurs:
within 7 days of starting with “no oral hygiene” period
A major difficulty in the effective use of antimicrobials in periodontal pockets has been the
rapid clearance of the active agent from the pocket.
Controlled-release drug delivery systems placed in periodontal pockets
release high concentrations of antimicrobials for up to 14 days.
According to a meta-analysis reported by Bonito et..al. in 2005, adjunctive use of a locally delivered antimicrobial (LDA) along with SRP will most likely add no more than an additional
0.05 mm to the reduction in probing depth obtained by SRP alone.
The active ingredient of the PerioChip is
Chlorhexidine.
Arestin is an LDA system that
releases minocycline from microspheres.
Gingival crevicular fluid (GCF) is a clear serous fluid from inflamed gingiva that is
a transudate of serum and tissue fluids.